Global Anesthesia Drugs Market 2017-2021

Overview of the global anesthesia drugs market

The global anesthesia drugs market is anticipated to grow at a steady rate and will post a CAGR of more than 3% during the forecast period. The growing volume of surgical procedures will drive the growth prospects for the global anesthesia drugs market in the coming years. Anesthesia is administered during various surgical procedures conducted to treat various diseases such as cardiovascular diseases, gastrointestinal diseases, urological disorders, spinal abnormalities, brain tumors, and orthopedic deformities. The rise in the number of surgical procedures in the European countries will aid in the growth of the market in these locations. For instance, the number of laparoscopic colectomy procedures doubled in Slovenia and tripled in Spain between 2008 and 2014.  Some of the surgeries performed in various ambulatory surgical centers (ASCs) include lens and cataract, hernia procedure, cervix and uterus removal, hysterectomy, and transurethral excision.

In terms of geography, the Americas accounted for the maximum market share during 2016 and will continue to dominate the market until the end of 2021. One of the major factors responsible for the market's growth in the US is the growing demand for propofol. Additionally, the increasing focus of a large number of vendors towards exploring new routes of administration such as oral and topical will also drive the preference for anesthetic drugs in the market. Analysts predict that the increasing demand for anesthesia in labor will also drive market growth. According to the Centers for Disease Control and Prevention (CDC), the total number of deliveries including vaginal and caesarean stood at 3,984,502 in the US.

Competitive landscape and key vendors

The global anesthesia drugs market is highly fragmented and competitive due to the presence of a large number of regional and international vendors across the globe. Also, it has been estimated that the competitive environment in the market will intensify due to the continuous advancements in technologies and drugs for new routes of administration (ROAs).

Key vendors in this market are -

• AbbVie
• Aspen
• Baxter
• B. Braun
• Fresenius Kabi

Other prominent vendors in the market include Air Liquide, Arbor Pharmaceuticals, Avera Pharmaceuticals, Eisai, GSK, Jiangsu HengRui Medicine, Johnson & Johnson, Lannett Company, Merck, Mydent International, Novalar Pharma, Nuvo Pharmaceuticals, Paion UK, Pfizer, Primex Pharmaceuticals, St. Renatus, Takeda, and The Medicines Company.

Segmentation by ROA and analysis of the anesthesia drugs market

• Parenteral
• Inhalational

The parenteral anesthesia segment accounted for the maximum market share during 2016 and will continue to dominate the market during the next few years as well. One of the major factors responsible for its increasing adoption among end-users is the fewer side effects in comparison to the inhalation therapy. Also, intravenous anesthesia is a segment of parenteral drugs, which is highly preferred by physicians because of its increased effectiveness.

Segmentation by type and analysis of the anesthesia drugs market

• Local and regional
• General anesthesia

The general anesthesia drugs segment accounted for the maximum market share during 2016 and will continue to dominate the market for the next four years. It has been estimated that the market will further benefit from the rising incidences of chronic respiratory diseases, cardiovascular diseases, craniomaxillofacial surgeries, and accidents along with the rapid adoption of propofol.

Key questions answered in the report include

• What will the market size and the growth rate be in 2021?
• What are the key factors driving the global anesthesia drugs market?
• What are the key market trends impacting the growth of the global anesthesia drugs market?
• What are the challenges to market growth?
• Who are the key vendors in the global anesthesia drugs market?
• What are the market opportunities and threats faced by the vendors in the global anesthesia drugs market?
• What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
• What are the key outcomes of the five forces analysis of the global anesthesia drugs market?

Technavio also offers customization on reports based on specific client requirement.

Related reports:

• Global Neuroendovascular Non-Coils Market 2016-2020
• Global Deep Brain Stimulation Market 2016-2020

By identifying short- and long-term trends in customer behavior, growth potential, competitors, and challenges, research analysts at Technavio provide a comprehensive collection of industry research reports on the various aspects of the orthopedics and general medical devices sector. With an up-to-date analysis, the market research experts from Technavio also provide detailed information on several vendors, including Drägerwerk, GE Healthcare, Maquet, Mindray Medical International, Penlon, Philips Healthcare, Meditec, Oricare, and Spacelabs Healthcare, who have established a strong presence in both the global and regional markets.

To identify the industry's growth prospects, the market research analysts at Technavio follow a triangulated mix of primary and secondary research techniques and consider factors like market size and the demand for various products across different geographical regions. Furthermore, by analyzing various parameters such as the changing preferences of customers and the products and services offered by competitors, our upcoming market research report on anesthesia drugs for the forecast period of 2017 to 2021 helps clients understand the constantly changing landscape for the orthopedics and general medical devices sector, which is an integral part of the global healthcare and life sciences industry.

This upcoming report on anesthesia drugs also considers the growth of similar markets such as anesthesia resuscitators and anesthesia delivery systems, which are expected to grow at a CAGR of more than 3% and more than 6%, respectively by 2020. Analysts identify that the increasing incidences of chronic disorders will foster the need for surgical procedures as one of the major factors that will fuel market growth. Increasing collaborations among hospitals and healthcare departments with anesthesia drug manufacturers will also increase the revenue shares of market players. In addition to syndicated reports, Technavio also offers to provide high-quality customized reports based on the requirements of the customers and helps businesses identify new growth opportunities and develop effective strategies to optimize their market positions.

The upcoming industry research report for anesthesia drugs also identifies the key drivers, emerging trends, as well as the challenges currently experienced by the healthcare and life sciences industry. It also presents insights into the changing competitive landscape to give clients a realistic picture of the future direction of the orthopedics and general medical devices sector.